Skip to main content

Canavan Disease clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • A Study of AAV9 Gene Therapy in Participants With Canavan Disease

    Sorry, not currently recruiting here

    The main objective of this trial is to evaluate the safety, tolerability, and pharmacodynamic activity of BBP-812, an investigational AAV9-based gene therapy, in pediatric participants with Canavan disease.

    Oakland, California and other locations

Our lead scientists for Canavan Disease research studies include .

Last updated: